Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease

  • Panisello, Carla|||0000-0002-8437-4418
  • Aschero, Rosario
  • Martnez-Moreno, Alba
  • Roca Ho, Heleia|||0000-0001-7324-5234
  • Falgàs, Aïda|||0000-0002-5040-2265
  • González-Navarro, Europa Azucena|||0000-0003-3310-5557
  • Carabelli, Julieta|||0000-0003-2329-3996
  • Pradenas, Edwards|||0000-0001-5162-8920
  • Lázaro-Díez, María|||0000-0002-6098-8052
  • Prado, Julia G.|||0000-0002-5439-4645
  • Blanco, Julià|||0000-0002-2225-0217
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Juan, Manel|||0000-0002-3064-1648
  • Carcaboso, Angel M.|||0000-0002-8485-426X
  • Bueno, Clara|||0000-0003-1442-6216
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
Humanized immunodeficient mice serve as critical models for investigating the functional interplay between transplanted human cells and a pre-reconstituted human immune system. These models facilitate the study of molecular and cellular pathogenic mechanisms and enable the evaluation of the efficacy and toxicity of immunotherapies, thereby accelerating their preclinical and clinical development. Current strategies rely on inefficient, long-term/delayed hematopoietic reconstitution by CD34+ hematopoietic progenitors or short-term reconstitution with peripheral blood mononuclear cells (PB-MNCs) associated with high rates of graft-versus-host disease (GvHD) and an inefficient representation of immune cell populations. Here, we hypothesized that immunologically naïve cord blood mononuclear cells (CB-MNCs) could serve as a superior alternative, providing long-lasting and functionally effective immune reconstitution. We conducted a comprehensive comparison between the non-obese diabetic (NOD).Cg-Prkdc∧ˆscid-IL2rg∧ˆtm1Wjl/SzJ (NSG) and NSG-Tg(CMV-IL3,CSF2,KITLG)∧ˆ1Eav/MloySzJ (NSGS) immunodeficient mouse models following humanization with either PB-MNCs or CB-MNCs. We assessed the engraftment dynamics of various human immune cells over time and monitored the development of GvHD in both models. For the most promising model, we extensively evaluated immune cell functionality in vitro and in vivo using sarcoma and leukemia xenografts. Humanizing NSGS mice with CB-MNCs results in a rapid, robust, and sustained representation of a diverse range of functional human lymphoid and myeloid cell populations while minimizing GvHD incidence. In this model, human immune cell populations significantly impair the growth and engraftment of sarcoma and B-cell acute lymphoblastic leukemia cells, with a significant inverse correlation between immune cell levels and tumor growth. This study establishes a fast, efficient, and reliable in vivo platform for various applications in cancer immunotherapy, particularly for exploring the complex interactions between cancer cells, immune cells, and the tumor microenvironment in vivo, prior to clinical development.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

  • Mensali, Nadia|||0000-0002-3130-4352
  • Köksal, Hakan
  • Joaquina, Sandy
  • Wernhoff, Patrick|||0000-0002-8111-9841
  • Casey, Nicholas P.
  • Romecín, Paola Alejandra|||0000-0001-6890-5883
  • Panisello, Carla|||0000-0002-8437-4418
  • Rodríguez, René|||0000-0002-0768-7306
  • Vimeux, Lene
  • Juzeniene, Asta
  • Myhre, Marit R.
  • Fåne, Anne
  • Castilla-Ramirez, Carolina
  • Maggadottir, Solrun Melkork
  • Duru, Adil Doganay|||0000-0002-5844-913X
  • Georgoudaki, Anna-Maria
  • Grad, Iwona
  • Maturana, Andrés Daniel
  • Gaudernack, Gustav
  • Kvalheim, Gunnar
  • Carcaboso, Angel M.|||0000-0002-8485-426X
  • De Álava, Enrique|||0000-0001-8400-046X
  • Donnadieu, Emma|||0000-0002-4985-7254
  • Bruland, Øyvind S.
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Inderberg, Else Marit
  • Wälchli, Sébastien|||0000-0001-5869-1746
Osteosarcoma (OS) remains a dismal malignancy in children and young adults, with poor outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising as in some other cancer types due to intra-tumor heterogeneity and considerable off-target expression of the potentially targetable proteins. Here we show that chimeric antigen receptor (CAR) T cells could successfully target an isoform of alkaline phosphatase, ALPL-1, which is highly and specifically expressed in primary and metastatic OS. The target recognition element of the second-generation CAR construct is based on two antibodies, previously shown to react against OS. T cells transduced with these CAR constructs mediate efficient and effective cytotoxicity against ALPL-positive cells in in vitro settings and in state-of-the-art in vivo orthotopic models of primary and metastatic OS, without unexpected toxicities against hematopoietic stem cells or healthy tissues. In summary, CAR-T cells targeting ALPL-1 show efficiency and specificity in treating OS in preclinical models, paving the path for clinical translation.